Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Laxative potency and acute toxicity of some anthraquinone derivatives, senna extracts and fractions of senna extracts.

Hietala P, Marvola M, Parviainen T, Lainonen H.

Pharmacol Toxicol. 1987 Aug;61(2):153-6.

PMID:
3671329
2.

Genotoxicity of sennosides on the bone marrow cells of mice.

Mukhopadhyay MJ, Saha A, Dutta A, De B, Mukherjee A.

Food Chem Toxicol. 1998 Nov;36(11):937-40.

PMID:
9771555
3.

No clastogenic activity of a senna extract in the mouse micronucleus assay.

Mengs U, Grimminger W, Krumbiegel G, Schuler D, Silber W, Völkner W.

Mutat Res. 1999 Aug 18;444(2):421-6.

PMID:
10521682
4.

Evaluation of the potential carcinogenic activity of Senna and Cascara glycosides for the rat colon.

Mereto E, Ghia M, Brambilla G.

Cancer Lett. 1996 Mar 19;101(1):79-83.

PMID:
8625286
5.

The effect of different storage conditions on the chemical stability, laxative effect and acute toxicity of sennoside solutions.

Lainonen H, Marvola M, Hietala P, Parviainen T.

Pharmacol Toxicol. 1988 Jul;63(1):37-41.

PMID:
3399476
6.

[Mechanism of action of sennosides].

Lemli J.

Bull Acad Natl Med. 1995 Nov;179(8):1605-11. Review. French.

PMID:
8717178
7.

An oral carcinogenicity and toxicity study of senna (Tinnevelly senna fruits) in the rat.

Mitchell JM, Mengs U, McPherson S, Zijlstra J, Dettmar P, Gregson R, Tigner JC.

Arch Toxicol. 2006 Jan;80(1):34-44. Epub 2005 Oct 5.

PMID:
16205914
8.

Assessment of the genotoxic risk from laxative senna products.

Brusick D, Mengs U.

Environ Mol Mutagen. 1997;29(1):1-9. Review.

PMID:
9020301
9.

Effects of long-term laxative treatment on rat mesenteric resistance vessel responses in vitro.

Ralevic V, Hoyle CH, Burnstock G.

Gastroenterology. 1990 Nov;99(5):1352-7.

PMID:
1698684
10.
11.

Mutagenicity of crude senna and senna glycosides in Salmonella typhimurium.

Sandnes D, Johansen T, Teien G, Ulsaker G.

Pharmacol Toxicol. 1992 Sep;71(3 Pt 1):165-72.

PMID:
1438037
12.

Senna: a laxative devoid of carcinogenic effects.

Borrelli F, Aviello G, Capasso R, Capasso F.

Arch Toxicol. 2006 Dec;80(12):873. No abstract available.

PMID:
17063369
13.

The senna drug and its chemistry.

Franz G.

Pharmacology. 1993 Oct;47 Suppl 1:2-6. Review.

PMID:
8234429
14.

Two-year carcinogenicity study with sennosides in the rat: emphasis on gastro-intestinal alterations.

Lydén-Sokolowski A, Nilsson A, Sjöberg P.

Pharmacology. 1993 Oct;47 Suppl 1:209-15.

PMID:
8234431
15.

Relevance of rhein excretion into breast milk.

Faber P, Strenge-Hesse A.

Pharmacology. 1988;36 Suppl 1:212-20.

PMID:
3368521
16.

Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides.

Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1353-7. Epub 2005 Jun 14.

PMID:
15956233
17.

A 13-week oral toxicity study of senna in the rat with an 8-week recovery period.

Mengs U, Mitchell J, McPherson S, Gregson R, Tigner J.

Arch Toxicol. 2004 May;78(5):269-75. Epub 2004 Feb 28.

PMID:
14997282
18.

The relative purgative activities of 1,8-dihydroxyanthracene derivatives.

Fairbairn JW, Moss MJ.

J Pharm Pharmacol. 1970 Aug;22(8):584-93. No abstract available.

PMID:
4394532
19.

The role of constitutive and inducible nitric oxide synthase in senna- and cascara-induced diarrhoea in the rat.

Izzo AA, Sautebin L, Rombolà L, Capasso F.

Eur J Pharmacol. 1997 Mar 26;323(1):93-7.

PMID:
9105882

Supplemental Content

Support Center